Indian pharmaceutical stocks opened the last trading session of April 2026 on a broadly weak note, with the majority of pharma scrips trading in the red in early trade. The S&P BSE Healthcare index was down 0.36% at 44,477.15, mirroring the broader market weakness — the S&P BSE Sensex fell 1.12% to 76,628.12 and Nifty 50 slipped 1.07% to 23,918.75.
Pharma Stock Prices Today — BSE and NSE (April 30, 2026)
| Company | BSE Price (₹) | BSE Change | NSE Price (₹) | NSE Change |
|---|---|---|---|---|
| Aarti Drugs | 372.50 | -0.33% | 376.00 | +0.71% |
| Ajanta Pharma | 2,812.45 | +0.26% | 2,818.90 | +0.52% |
| Alembic Pharma | 757.00 | -0.58% | 759.35 | -0.23% |
| Aurobindo Pharma | 1,393.40 | -0.22% | 1,395.70 | -0.08% |
| Biocon | 358.65 | -1.01% | 359.75 | -0.69% |
| Cipla | 1,316.55 | -0.01% | 1,317.00 | -0.05% |
| Divis Laboratories | 6,485.00 | -0.77% | 6,495.00 | -0.60% |
| Dr. Reddy’s Laboratories | 1,328.95 | -0.09% | 1,331.20 | +0.11% |
| Glenmark Pharma | 2,416.25 | +0.23% | 2,430.00 | +0.67% |
| Indoco Remedies | 210.20 | +0.48% | 210.39 | +0.42% |
| IPCA Labs | 1,554.00 | +0.79% | 1,561.80 | +1.28% |
| J.B. Chemicals | 2,045.05 | -0.87% | 2,049.90 | -0.55% |
| Lupin | 2,295.90 | -0.65% | 2,299.20 | -0.53% |
| Mankind Pharma | 2,236.10 | -0.82% | 2,250.10 | -0.30% |
| Natco Pharma | 1,100.00 | +0.58% | 1,104.40 | +0.99% |
| Orchid Pharma | 617.40 | +1.19% | 620.50 | +1.25% |
| Panacea Biotech | 366.55 | -0.89% | 367.60 | -0.85% |
| Strides Pharma Science | 1,047.30 | -0.56% | 1,049.10 | -0.41% |
| Sudeep Pharma Ltd. | 686.05 | -0.87% | 690.10 | -0.39% |
| Sun Pharma | 1,773.90 | -0.28% | 1,775.60 | -0.17% |
| Torrent Pharma | 4,187.35 | -1.01% | 4,191.10 | -0.95% |
| Wockhardt | 1,394.60 | +0.13% | 1,405.00 | +0.96% |
| Zydus Lifesciences | 902.70 | -0.85% | 903.30 | -0.83% |
Gainers in the Pharma Space Today
A handful of pharma stocks bucked the broader downtrend in early trade:
- Orchid Pharma was the top gainer among the tracked stocks, up 1.19% on BSE and 1.25% on NSE, trading at ₹617.40 and ₹620.50 respectively.
- IPCA Labs gained 0.79% on BSE and 1.28% on NSE, trading at ₹1,554.00 and ₹1,561.80.
- Natco Pharma was up 0.58% on BSE and 0.99% on NSE at ₹1,100.00 and ₹1,104.40.
- Indoco Remedies added 0.48% on BSE and 0.42% on NSE, trading at ₹210.20 and ₹210.39.
- Ajanta Pharma edged up 0.26% on BSE and 0.52% on NSE at ₹2,812.45 and ₹2,818.90.
- Glenmark Pharma rose 0.23% on BSE and 0.67% on NSE at ₹2,416.25 and ₹2,430.00.
- Wockhardt was marginally in the green — up 0.13% on BSE and 0.96% on NSE.
Losers in the Pharma Space Today
The majority of pharma counters were trading lower in line with a weak broader market:
- Biocon and Torrent Pharma were the steepest fallers among large-cap pharma names, both down around 1.01% on BSE.
- J.B. Chemicals fell 0.87% on BSE and 0.55% on NSE.
- Panacea Biotech and Sudeep Pharma dropped 0.89% and 0.87% respectively on BSE.
- Zydus Lifesciences was down 0.85% on BSE and 0.83% on NSE.
- Mankind Pharma declined 0.82% on BSE.
- Lupin slipped 0.65% on BSE.
- Divis Laboratories fell 0.77% on BSE, trading at ₹6,485.00 — one of the higher-priced pharma stocks on the list.
- Alembic Pharma, Strides Pharma Science, and Sun Pharma were each down between 0.17% and 0.58%.
- Aurobindo Pharma and Cipla were the most marginal movers, each declining less than 0.25%.
Disclaimer
The prices listed above are early morning snapshots from BSE (as of 9:33 AM) and NSE (as of 9:34 AM) on April 30, 2026. Stock prices change continuously during market hours. This article is for informational purposes only and does not constitute investment advice. Please verify prices on BSE/NSE official platforms before making any investment decision.